Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7745795 | 0.89 | MEN1 (0.43) | TSHRPOLBMAPTSMN1; SMN2TP53 | |
| SCHEMBL7745971 | 0.87 | TP53 (0.34) | TSHRPOLBPTK2BMAPTSMN1; SMN2 | |
| SCHEMBL7741391 | 0.85 | CYP3A4 (0.37) | — | |
| SCHEMBL7745443 | 0.80 | CYP3A4 (0.37) | TSHRPOLBPTK2BMAPTSMN1; SMN2 | |
| SCHEMBL7741673 | 0.80 | CYP3A4 (0.43) | TSHRPOLBPTK2BMAPTSMN1; SMN2 | |
| SCHEMBL7745784 | 0.79 | CYP3A4 (0.40) | TSHRPOLBPTK2BMAPTSMN1; SMN2 | |
| SCHEMBL7746108 | 0.77 | TSHR (0.33) | TSHRPOLBPTK2BMAPTSMN1; SMN2 | |
| SCHEMBL7746216 | 0.77 | MAPT (0.38) | TSHRPOLBPTK2BMAPTSMN1; SMN2 | |
| SCHEMBL6499879 | 0.76 | CNR2 (0.37) | — | |
| SCHEMBL6499872 | 0.76 | CNR2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6774134-B2 | FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-10 | — | — | US | disclosed |